US stock · Healthcare sector · Pharmaceutical Retailers
Company Logo

Rite Aid Corporation

RADNYSE

7.01

USD
-0.07
(-0.99%)
Market Closed
-0.60P/E
-5Forward P/E
-0.03P/E to S&P500
389.944MMarket CAP
- -Div Yield

Rite Aid Corporation

NYSE:RAD

RECENT
PRICE

7.01

P/E
RATIO

-0.60

(PEG:- -)

P/E RATIO
RELATIVE
TO S&P

-0.03

DIV
YLD

0.00%

High:
Low:

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

Legends

Stock price

1.03 Beta (1.0 Market)

0

0

0

0

0

0

0

0

0

-

% total return 09/22:

Stock

S&P

1y.

0

0

3y.

0

0

5y.

0

0

0

Percent shares traded:

0

0

0

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

TTM

Fiscal year

756.45

1.17

(2.36)

0.66

672.09

(29.81)

(18.26)

0.42

625.33

(69.35)

(4.32)

0.08

582.83

(11.51)

(11.78)

- -

571.16

(12.57)

4.74

- -

589.76

(8.33)

0.37

- -

570.89

2.65

9.82

- -

553.59

5.40

6.09

- -

546.36

43.44

2.26

- -

405.52

3.23

6.39

- -

439.05

0.08

(4.89)

- -

410.22

17.98

0.98

- -

409.42

(7.99)

(8.96)

- -

411.97

(8.50)

5.12

- -

448.12

(1.69)

(3.76)

- -

454.50

(9.96)

2.93

- -

450.85

(11.74)

(2.14)

- -

Revenue per share

Earnings per share

Free Cash Flow per sh

Dividends per share

15.72

71.84

20.45

47.28

12.88

(28.54)

4.40

(38.00)

4.22

(50.09)

5.65

(58.40)

8.61

(55.30)

9.14

(45.84)

11.11

1.18

13.08

11.35

9.21

11.76

4.09

30.51

4.63

22.45

4.03

12.67

4.19

11.47

4.08

1.83

4.23

4.93

CAPEX per share

Book Value per share

23

36

42

44

44

44

44

46

49

51

52

52

53

53

54

54

54

Comm.Shares outs.(m)

91.5

5.3

0.6%

(1.1)

(0.1)

1.3%

(0.3)

(0.0)

0.4%

(2.0)

(0.1)

- -

(1.9)

(0.1)

- -

(3.2)

(0.2)

- -

24.6

1.4

- -

23.6

1.3

- -

3.7

0.2

- -

47.6

2.1

- -

908.6

38.5

- -

1.8

0.1

- -

(1.4)

(0.1)

- -

(1.6)

(0.0)

- -

(10.7)

(0.4)

- -

(0.9)

(0.0)

- -

(0.6)

(0.0)

- -

Avg. annual P/E ratio

P/E relative to S&P500

Avg. annual div. yield

Capital Structure (28/5/22 | Q1)

Total liabilities
$8,558 m.

Total assets
$8,550 m.

Long-term debt
$5,567 m.

Cash and equiv.
$56 m.

Goodwill $879 m.

Retained earnings $(5,962) m.

Common stock 54 m. shares

Market Capitalisation
$390 m. (as of 25/9/22)

26,121

1.0%

25,392

2.8%

25,526

3.0%

26,528

3.3%

20,770

3.9%

22,928

2.3%

21,529

0.6%

21,640

0.4%

21,928

0.6%

24,043

0.2%

24,568

0.3%

24,422

0.0%

Revenue (m)

Operating margin

441

(369)

414

118

404

249

417

2,109

509

165

568

4

386

943

358

(422)

328

(452)

327

(91)

296

(538)

290

(636)

Depreciation (m)

Net profit (m)

6.0%

(1.4)%

(1,382.5)%

0.5%

0.3%

1.0%

(394.2)%

8.0%

74.5%

0.8%

91.5%

0.0%

(702.7)%

4.4%

(13.1)%

(2.0)%

(474.9)%

(2.1)%

16.8%

(0.4)%

0.7%

(2.2)%

(0.5)%

(2.6)%

Income tax rate

Net profit margin

1,935

6,249

(2,587)

1,831

5,996

(2,459)

1,778

5,708

(2,114)

1,737

5,483

57

1,554

6,967

581

2,060

3,273

614

1,271

3,371

1,601

1,659

3,479

1,187

934

3,077

675

992

5,909

615

516

5,345

99

741

5,567

(8)

Working capital (m)

Long-term debt (m)

Equity (m)

2.7%

1.9%

14.3%

172.2%

7.4%

(4.8)%

15.1%

9.7%

(11.8)%

63.9%

9.3%

3,696.7%

2.2%

6.5%

28.5%

0.5%

4.1%

0.7%

211.0%

16.2%

58.9%

(2.6)%

(1.5)%

(35.6)%

14.2%

1.7%

(67.0)%

1.1%

1.0%

(14.8)%

(6.2)%

(4.1)%

(543.7)%

(7.8)%

(5.2)%

7,588.5%

ROIC

Return on capital

Return on equity

Working Capital

2020

2021

2022

Cash assets

218

161

40

Receivables

1,287

1,462

1,343

Inventory

1,922

1,865

1,959

Other

274

107

107

Current assets

3,701

3,595

3,449

Acc. Payable

1,484

1,437

1,571

Debt due

9

523

581

Other

1,274

642

781

Current liab.

2,766

2,603

2,933

100.0%

- -

100.0%

(0.4)%

100.0%

(4.3)%

100.0%

(22.0)%

100.0%

(3.5)%

100.0%

2.7%

100.0%

(11.2)%

100.0%

- -

100.0%

- -

100.0%

- -

100.0%

- -

100.0%

- -

Plowback ratio

Div.&Repurch. to FCF

Rite Aid Corporation (US) started trading on May 5, 1981 (cik: 0000084129), operates in the Healthcare sector (Pharmaceutical Retailers industry), has 53,000 full-time employees, and is led by Ms. Heyward Donigan. Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

Annual rates

(avg rate of change)

Past
5 y.

Past
10 y.

Revenues

3.42%

0.08%

Cash flow

-381.97%

-191.55%

Earnings

68.69%

2680.16%

Dividends

- -

- -

Book value

-40.44%

89.65%

Insider trading

Type

Shares

Date

Gilbert Paul D

InKind

2,728

08/17/22

Donigan Heyward R

InKind

37,370

08/12/22

Miramontes Louis

Award

21,505

07/27/22

Mennen Justin L.

Award

49,509

07/27/22

Nayar Arun

Award

21,505

07/27/22

Fiscal Year Ends

Quarterly Revenue (m)

Full fiscal year

I

II

III

IV

2021

6,027

5,982

6,117

5,917

24,043

2022

6,161

6,113

6,229

6,065

24,568

2023

6,015

- -

- -

- -

- -

Fiscal Year Ends

Earnings per share

Full fiscal year

I

II

III

IV

2021

(1.18)

(0.25)

0.08

(0.34)

-1.69

2022

(0.24)

(1.86)

(0.67)

(7.20)

-9.96

2023

(2.03)

- -

- -

- -

- -

Fiscal Year Ends

Quarterly dividends paid

Full fiscal year

I

II

III

IV

2021

- -

- -

- -

- -

- -

2022

- -

- -

- -

- -

- -

2023

- -

- -

- -

- -

- -

09/23/2021

BlackBerry, Lucid, Nike: What to Watch When the Stock Market Opens Today

The Wall Street Journal - Read more...